LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lyophilized Control Monitors Precision of Tumor Marker Testing

By LabMedica International staff writers
Posted on 12 Feb 2009
A lyophilized quality control based on human serum, monitors the precision of tumor marker testing procedures.

The Lyphochek tumor marker plus control includes high target levels of cancer antigens and ferritin, as well as a very low level of prostate-specific antigen (PSA). It has a three-year shelf life when stored at 2-8 ºC. Its reconstituted stability is 14 days at 2-8 ºC and 30 days at -20-70 °C (for most analytes).

Assayed values are provided for manual and automated test methods. The Unity Interlaboratory Program with peer group comparison is available for use with the Lyphochek tumor marker plus control. The Unity Interlaboratory Program is an expert data management software system designed to improve the effectiveness of quality control processes.

Launched by Bio-Rad Laboratories, (Hercules, CA, USA), a multinational manufacturer and distributor of clinical diagnostic products, the Lyphochek multianalyte control features 23 tumor markers. Being a blood-based material, the control can be processed in the same manner as patient samples, ensuring quality on an ongoing basis.

Bio-Rad products are used worldwide by laboratories, hospitals, universities, major research institutions, as well as biotechnology and pharmaceutic companies.

Related Links:

Bio-Rad Laboratories




New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
Hemodynamic System Monitor
OptoMonitor
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay

Latest Immunology News

Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
12 Feb 2009  |   Immunology

Signature Genes Predict T-Cell Expansion in Cancer Immunotherapy
12 Feb 2009  |   Immunology

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection
12 Feb 2009  |   Immunology



GLOBE SCIENTIFIC, LLC